PPAPDC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.022800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.081990E-01
Normal-vs-Stage2
5.839700E-04
Normal-vs-Stage3
2.676500E-03
Normal-vs-Stage4
2.819600E-01
Stage1-vs-Stage2
3.538200E-01
Stage1-vs-Stage3
9.651600E-02
Stage1-vs-Stage4
8.853600E-01
Stage2-vs-Stage3
1.197370E-01
Stage2-vs-Stage4
6.135000E-01
Stage3-vs-Stage4
2.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.404900E-04
Normal-vs-AfricanAmerican
8.556700E-03
Normal-vs-Asian
1.074040E-01
Caucasian-vs-AfricanAmerican
5.426400E-01
Caucasian-vs-Asian
6.671200E-01
AfricanAmerican-vs-Asian
9.670200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.384320E-03
Normal-vs-Female
1.317670E-03
Male-vs-Female
8.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.840200E-02
Normal-vs-Age(41-60Yrs)
3.582100E-03
Normal-vs-Age(61-80Yrs)
9.620100E-04
Normal-vs-Age(81-100Yrs)
8.881200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.496400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.132000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.488200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.784200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.515200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.267600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.564900E-03
Normal-vs-Daily Drinker
6.4647999999945E-05
Normal-vs-Weekly Drinker
1.054420E-01
Normal-vs-Occasional Drinker
1.949570E-02
Normal-vs-Social Drinker
4.763000E-03
Non Drinker-vs-Daily Drinker
1.594590E-01
Non Drinker-vs-Weekly Drinker
4.297000E-01
Non Drinker-vs-Occasional Drinker
5.338800E-01
Non Drinker-vs-Social Drinker
7.644600E-01
Daily Drinker-vs-Weekly Drinker
1.275430E-01
Daily Drinker-vs-Occasional Drinker
5.302000E-02
Daily Drinker-vs-Social Drinker
8.342100E-02
Weekly Drinker-vs-Occasional Drinker
8.023600E-01
Weekly Drinker-vs-Social Drinker
6.368400E-01
Occasional Drinker-vs-Social Drinker
7.630400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.946300E-02
Normal-vs-Grade 2
1.094360E-01
Normal-vs-Grade 3
2.250200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.107800E-01
Grade 1-vs-Grade 3
4.468400E-01
Grade 1-vs-Grade 4
3.946300E-02
Grade 2-vs-Grade 3
3.037800E-01
Grade 2-vs-Grade 4
1.094360E-01
Grade 3-vs-Grade 4
2.250200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.184200E-03
Normal-vs-NonDiabetic
4.383700E-04
Diabetic-vs-NonDiabetic
8.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.029100E-04
Normal-vs-NoPancreatitis
4.789500E-04
Pancreatitis-vs-NoPancreatitis
4.219600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.375500E-03
Normal-vs-N1
8.47090000000161E-05
N0-vs-N1
3.852000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.869020E-01
Normal-vs-TP53-NonMutant
9.223900E-02
TP53-Mutant-vs-TP53-NonMutant
1.398770E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
